278 filings
20-F
2023 FY
ENLV
Enlivex Therapeutics Ltd
Annual report (foreign)
30 Apr 24
4:31pm
6-K
ENLV
Enlivex Therapeutics Ltd
29 Apr 24
Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events
8:01am
6-K
ENLV
Enlivex Therapeutics Ltd
22 Apr 24
Report of Foreign Private Issuer
8:02am
6-K
ENLV
Enlivex Therapeutics Ltd
16 Apr 24
Report of Foreign Private Issuer
8:00am
6-K
ENLV
Enlivex Therapeutics Ltd
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
6-K
zk0a5z0w9j9wy19olg
29 Mar 24
Report of Foreign Private Issuer
4:30pm
6-K
mk3iemzzhtf1y9
7 Feb 24
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method
8:02am
6-K
xb74zwrybb07bs0v6
22 Jan 24
Report of Foreign Private Issuer
8:00am
6-K
isgxr
17 Jan 24
Report of Foreign Private Issuer
8:02am
6-K
6n7az3dk0i tlhb
20 Dec 23
Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
8:01am
6-K
gn721y dt6
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
6-K
l2j9hxc1sf vr
7 Nov 23
Report of Foreign Private Issuer
4:30pm
6-K
7199ogi38ytyy3fsng
2 Nov 23
Report of Foreign Private Issuer
4:30pm
6-K
lafv p4zw6
26 Oct 23
Report of Foreign Private Issuer
4:30pm
6-K
sr4dz4lm7afo8gz
18 Sep 23
Report of Foreign Private Issuer
8:00am
6-K
j1ri73 1d8
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
5divqiwdy ymoui6j
11 Sep 23
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
8:00am
6-K
849ly0ndn09y
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
0dgrtfo2zy0 g0o0
2 Aug 23
Report of Foreign Private Issuer
8:05am
6-K
0zd68vnuaw0 mw
31 Jul 23
Enlivex Announces Dosing of First Patient Under The Amended Protocol Of Its Phase II trial Evaluating Allocetra™ In Patients With Sepsis
8:05am